Drug Name and FDA Application Number | Dosage Form/Route | Strength | Marketing Status | Company |
EPIRUBICIN HYDROCHLORIDE
(NDA # 050807)
| INJECTABLE; IV (INFUSION) |
50MG/VIAL 200MG/VIAL
|
Prescription
| HOSPIRA |
EPIRUBICIN HYDROCHLORIDE
(ANDA # 065289)
| INJECTABLE; INJECTION |
50MG/25ML (2MG/ML) 200MG/100ML (2MG/ML)
|
Prescription
| BEDFORD |
EPIRUBICIN HYDROCHLORIDE
(ANDA # 065331)
| INJECTABLE; INJECTION |
50MG/25ML (2MG/ML) 200MG/100ML (2MG/ML)
|
Prescription
| TEVA PARENTERAL |
EPIRUBICIN HYDROCHLORIDE
(ANDA # 065343)
| INJECTABLE; INJECTION |
10MG/5ML (2MG/ML) 50MG/25ML (2MG/ML) 150MG/75ML (2MG/ML) 200MG/100ML (2MG/ML)
|
Prescription
| HOSPIRA |
EPIRUBICIN HYDROCHLORIDE
(ANDA # 065361)
| INJECTABLE; INJECTION |
50MG/25ML (2MG/ML) 200MG/100ML (2MG/ML)
|
Prescription
| WATSON LABS |
EPIRUBICIN HYDROCHLORIDE
(ANDA # 065408)
| INJECTABLE; INJECTION |
10MG/5ML (2MG/ML) 50MG/25ML (2MG/ML) 150MG/75ML (2MG/ML) 200MG/100ML (2MG/ML)
|
Prescription
| ABRAXIS PHARM PRODS |
EPIRUBICIN HYDROCHLORIDE
(ANDA # 065411)
| INJECTABLE; INJECTION |
200MG/100ML (2MG/ML) 50MG/25ML (2MG/ML)
|
Prescription
| DABUR ONCOLOGY PLC |